1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Conjunctival Scarring: new trials by email Literature Review of Conjunctival Scarring trials Research Report on Conjunctival Scarring
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bleb Vascularity Change After Subconjunctival Injection Bevacizumab bevacizumab - Bleb Vascularity, Conjunctival Scarring | Phase 4 | Unknown | Capital Medical University | 30 | 2008-12-01 | 2008-12-30 |
Blister (1)
Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin Diseases, Vesiculobullous (1) · Skin and Connective Tissue Diseases (1)
Bevacizumab (1)
Capital Medical University (1)
China (1)
Liu Xuan, M.D. (1)